ID   TEC_HUMAN               Reviewed;         631 AA.
AC   P42680; B7ZKZ6; Q3MIS5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   12-OCT-2022, entry version 205.
DE   RecName: Full=Tyrosine-protein kinase Tec;
DE            EC=2.7.10.2;
GN   Name=TEC; Synonyms=PSCTK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7934162;
RA   Sato K., Mano H., Ariyama T., Inazawa J., Yazaki Y., Hirai H.;
RT   "Molecular cloning and analysis of the human Tec protein-tyrosine kinase.";
RL   Leukemia 8:1663-1672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 203-206, AND PHOSPHORYLATION AT TYR-206.
RX   PubMed=12573241; DOI=10.1016/s1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [5]
RP   PHOSPHORYLATION, INTERACTION WITH KIT, AND ACTIVITY REGULATION.
RX   PubMed=7526158; DOI=10.1128/mcb.14.12.8432-8437.1994;
RA   Tang B., Mano H., Yi T., Ihle J.N.;
RT   "Tec kinase associates with c-kit and is tyrosine phosphorylated and
RT   activated following stem cell factor binding.";
RL   Mol. Cell. Biol. 14:8432-8437(1994).
RN   [6]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9299487; DOI=10.1006/bbrc.1997.7269;
RA   Laffargue M., Monnereau L., Tuech J., Ragab A., Ragab-Thomas J.,
RA   Payrastre B., Raynal P., Chap H.;
RT   "Integrin-dependent tyrosine phosphorylation and cytoskeletal translocation
RT   of Tec in thrombin-activated platelets.";
RL   Biochem. Biophys. Res. Commun. 238:247-251(1997).
RN   [7]
RP   ACTIVITY REGULATION.
RX   PubMed=9341160; DOI=10.1074/jbc.272.43.27178;
RA   Ohya K., Kajigaya S., Yamashita Y., Miyazato A., Hatake K., Miura Y.,
RA   Ikeda U., Shimada K., Ozawa K., Mano H.;
RT   "SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase.";
RL   J. Biol. Chem. 272:27178-27182(1997).
RN   [8]
RP   INTERACTION WITH GRB10, AND FUNCTION IN PHOSPHORYLATION OF GRB10.
RX   PubMed=9753425; DOI=10.1046/j.1365-2443.1998.00201.x;
RA   Mano H., Ohya K., Miyazato A., Yamashita Y., Ogawa W., Inazawa J.,
RA   Ikeda U., Shimada K., Hatake K., Kasuga M., Ozawa K., Kajigaya S.;
RT   "Grb10/GrbIR as an in vivo substrate of Tec tyrosine kinase.";
RL   Genes Cells 3:431-441(1998).
RN   [9]
RP   PHOSPHORYLATION, ACTIVITY REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9652744; DOI=10.1038/sj.onc.1201799;
RA   Hamazaki Y., Kojima H., Mano H., Nagata Y., Todokoro K., Abe T.,
RA   Nagasawa T.;
RT   "Tec is involved in G protein-coupled receptor- and integrin-mediated
RT   signalings in human blood platelets.";
RL   Oncogene 16:2773-2779(1998).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF STAP1, AND ACTIVITY REGULATION.
RX   PubMed=10518561; DOI=10.1073/pnas.96.21.11976;
RA   Ohya K., Kajigaya S., Kitanaka A., Yoshida K., Miyazato A., Yamashita Y.,
RA   Yamanaka T., Ikeda U., Shimada K., Ozawa K., Mano H.;
RT   "Molecular cloning of a docking protein, BRDG1, that acts downstream of the
RT   Tec tyrosine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11976-11981(1999).
RN   [11]
RP   INTERACTION WITH INPP5D AND INPPL1.
RX   PubMed=15492005; DOI=10.1074/jbc.m408141200;
RA   Tomlinson M.G., Heath V.L., Turck C.W., Watson S.P., Weiss A.;
RT   "SHIP family inositol phosphatases interact with and negatively regulate
RT   the Tec tyrosine kinase.";
RL   J. Biol. Chem. 279:55089-55096(2004).
RN   [12]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-206 AND TYR-228, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-519, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=19883687; DOI=10.1016/j.imlet.2009.10.009;
RA   Susaki K., Kitanaka A., Dobashi H., Kubota Y., Kittaka K., Kameda T.,
RA   Yamaoka G., Mano H., Mihara K., Ishida T.;
RT   "Tec protein tyrosine kinase inhibits CD25 expression in human T-
RT   lymphocyte.";
RL   Immunol. Lett. 127:135-142(2010).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF FGF2, AND INTERACTION WITH FGF2.
RX   PubMed=20230531; DOI=10.1111/j.1600-0854.2010.01059.x;
RA   Ebert A.D., Laussmann M., Wegehingel S., Kaderali L., Erfle H.,
RA   Reichert J., Lechner J., Beer H.D., Pepperkok R., Nickel W.;
RT   "Tec-kinase-mediated phosphorylation of fibroblast growth factor 2 is
RT   essential for unconventional secretion.";
RL   Traffic 11:813-826(2010).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-44 AND LYS-563.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine kinase that contributes to signaling
CC       from many receptors and participates as a signal transducer in multiple
CC       downstream pathways, including regulation of the actin cytoskeleton.
CC       Plays a redundant role to ITK in regulation of the adaptive immune
CC       response. Regulates the development, function and differentiation of
CC       conventional T-cells and nonconventional NKT-cells. Required for TCR-
CC       dependent IL2 gene induction. Phosphorylates DOK1, one CD28-specific
CC       substrate, and contributes to CD28-signaling. Mediates signals that
CC       negatively regulate IL2RA expression induced by TCR cross-linking.
CC       Plays a redundant role to BTK in BCR-signaling for B-cell development
CC       and activation, especially by phosphorylating STAP1, a BCR-signaling
CC       protein. Required in mast cells for efficient cytokine production.
CC       Involved in both growth and differentiation mechanisms of myeloid cells
CC       through activation by the granulocyte colony-stimulating factor CSF3, a
CC       critical cytokine to promoting the growth, differentiation, and
CC       functional activation of myeloid cells. Participates in platelet
CC       signaling downstream of integrin activation. Cooperates with JAK2
CC       through reciprocal phosphorylation to mediate cytokine-driven
CC       activation of FOS transcription. GRB10, a negative modifier of the FOS
CC       activation pathway, is another substrate of TEC. TEC is involved in G
CC       protein-coupled receptor- and integrin-mediated signalings in blood
CC       platelets. Plays a role in hepatocyte proliferation and liver
CC       regeneration and is involved in HGF-induced ERK signaling pathway.
CC       TEC regulates also FGF2 unconventional secretion (endoplasmic reticulum
CC       (ER)/Golgi-independent mechanism) under various physiological
CC       conditions through phosphorylation of FGF2 'Tyr-215'. May also be
CC       involved in the regulation of osteoclast differentiation.
CC       {ECO:0000269|PubMed:10518561, ECO:0000269|PubMed:19883687,
CC       ECO:0000269|PubMed:20230531, ECO:0000269|PubMed:9753425}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by tyrosine phosphorylation by a wide
CC       range of cytokine stimulations. When T-cells or B-cells receptors are
CC       activated, a series of phosphorylation leads to the recruitment of
CC       TEC to the cell membrane, where it is phosphorylated at Tyr-519. Also
CC       activated in response to SCF. Integrin engagement induces tyrosine
CC       phosphorylation of TEC in platelets. STAP1 participates in a positive
CC       feedback loop by increasing the activity of TEC. SOCS1 is an inhibitor
CC       of TEC kinase activity. {ECO:0000269|PubMed:10518561,
CC       ECO:0000269|PubMed:7526158, ECO:0000269|PubMed:9341160,
CC       ECO:0000269|PubMed:9652744}.
CC   -!- SUBUNIT: Interacts with INPP5D/SHIP1 and INPPL1/SHIP2. Interacts with
CC       CD28, FASLG, FGF2, GRB10, LYN and KIT. Interacts with VAV1 and JAK2 (By
CC       similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P42680; P78325: ADAM8; NbExp=2; IntAct=EBI-1383480, EBI-2625954;
CC       P42680; Q13480: GAB1; NbExp=2; IntAct=EBI-1383480, EBI-517684;
CC       P42680; P08581: MET; NbExp=2; IntAct=EBI-1383480, EBI-1039152;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral membrane
CC       protein. Cytoplasm, cytoskeleton. Note=Following B-cell or T-cell
CC       receptors activation by antigen, translocates to the plasma membrane
CC       through its PH domain. Thrombin and integrin engagement induces
CC       translocation of TEC to the cytoskeleton during platelet activation. In
CC       cardiac myocytes, assumes a diffuse intracellular localization under
CC       basal conditions but is recruited to striated structures upon various
CC       stimuli, including ATP (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in a wide range of cells, including
CC       hematopoietic cell lines like myeloid, B-, and T-cell lineages.
CC   -!- DOMAIN: The PH domain mediates the binding to inositol polyphosphate
CC       and phosphoinositides, leading to its targeting to the plasma membrane.
CC       It is extended in the BTK kinase family by a region designated the TH
CC       (Tec homology) domain, which consists of about 80 residues preceding
CC       the SH3 domain.
CC   -!- DOMAIN: The SH3 domain is essential for its targeting to activated CD28
CC       costimulatory molecule. {ECO:0000250}.
CC   -!- PTM: Following B-cell or T-cell receptors engagement, translocates to
CC       the plasma membrane where it gets phosphorylated at Tyr-519. Undergoes
CC       also tyrosine phosphorylation during platelet activation.
CC       {ECO:0000269|PubMed:12573241, ECO:0000269|PubMed:7526158,
CC       ECO:0000269|PubMed:9299487, ECO:0000269|PubMed:9652744}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- CAUTION: It is uncertain whether Met-1 is the initiator. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D29767; BAA06171.1; -; mRNA.
DR   EMBL; CH471069; EAW93055.1; -; Genomic_DNA.
DR   EMBL; BC101711; AAI01712.1; -; mRNA.
DR   EMBL; BC101713; AAI01714.1; -; mRNA.
DR   EMBL; BC143487; AAI43488.1; -; mRNA.
DR   CCDS; CCDS3481.1; -.
DR   PIR; I38268; I38268.
DR   PIR; I56997; I56997.
DR   RefSeq; NP_003206.2; NM_003215.2.
DR   PDB; 2LUL; NMR; -; A=1-154.
DR   PDBsum; 2LUL; -.
DR   AlphaFoldDB; P42680; -.
DR   BMRB; P42680; -.
DR   SMR; P42680; -.
DR   BioGRID; 112865; 33.
DR   IntAct; P42680; 38.
DR   MINT; P42680; -.
DR   STRING; 9606.ENSP00000370912; -.
DR   BindingDB; P42680; -.
DR   ChEMBL; CHEMBL4246; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB15035; Zanubrutinib.
DR   DrugCentral; P42680; -.
DR   GuidetoPHARMACOLOGY; 2238; -.
DR   iPTMnet; P42680; -.
DR   PhosphoSitePlus; P42680; -.
DR   BioMuta; TEC; -.
DR   DMDM; 158518392; -.
DR   EPD; P42680; -.
DR   jPOST; P42680; -.
DR   MassIVE; P42680; -.
DR   MaxQB; P42680; -.
DR   PaxDb; P42680; -.
DR   PeptideAtlas; P42680; -.
DR   PRIDE; P42680; -.
DR   ProteomicsDB; 55526; -.
DR   ABCD; P42680; 3 sequenced antibodies.
DR   Antibodypedia; 715; 350 antibodies from 32 providers.
DR   DNASU; 7006; -.
DR   Ensembl; ENST00000381501.8; ENSP00000370912.3; ENSG00000135605.13.
DR   GeneID; 7006; -.
DR   KEGG; hsa:7006; -.
DR   MANE-Select; ENST00000381501.8; ENSP00000370912.3; NM_003215.3; NP_003206.2.
DR   UCSC; uc003gxz.4; human.
DR   CTD; 7006; -.
DR   DisGeNET; 7006; -.
DR   GeneCards; TEC; -.
DR   HGNC; HGNC:11719; TEC.
DR   HPA; ENSG00000135605; Low tissue specificity.
DR   MalaCards; TEC; -.
DR   MIM; 600583; gene.
DR   neXtProt; NX_P42680; -.
DR   OpenTargets; ENSG00000135605; -.
DR   PharmGKB; PA36436; -.
DR   VEuPathDB; HostDB:ENSG00000135605; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   GeneTree; ENSGT00940000155951; -.
DR   HOGENOM; CLU_000288_7_2_1; -.
DR   InParanoid; P42680; -.
DR   OMA; PEVIEYH; -.
DR   OrthoDB; 1047190at2759; -.
DR   PhylomeDB; P42680; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; P42680; -.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   SignaLink; P42680; -.
DR   SIGNOR; P42680; -.
DR   BioGRID-ORCS; 7006; 14 hits in 1100 CRISPR screens.
DR   ChiTaRS; TEC; human.
DR   GeneWiki; TEC_(gene); -.
DR   GenomeRNAi; 7006; -.
DR   Pharos; P42680; Tchem.
DR   PRO; PR:P42680; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; P42680; protein.
DR   Bgee; ENSG00000135605; Expressed in lower esophagus mucosa and 95 other tissues.
DR   ExpressionAtlas; P42680; baseline and differential.
DR   Genevisible; P42680; HS.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; NAS:BHF-UCL.
DR   GO; GO:0043621; F:protein self-association; IPI:BHF-UCL.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0002250; P:adaptive immune response; IBA:GO_Central.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0010543; P:regulation of platelet activation; IDA:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0042246; P:tissue regeneration; IBA:GO_Central.
DR   CDD; cd11905; SH3_Tec; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR035572; Tec_SH3.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00402; TECBTKDOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Cell membrane; Cytoplasm;
KW   Cytoskeleton; Direct protein sequencing; Immunity; Kinase; Lipid-binding;
KW   Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase; Zinc; Zinc-finger.
FT   CHAIN           1..631
FT                   /note="Tyrosine-protein kinase Tec"
FT                   /id="PRO_0000088170"
FT   DOMAIN          4..111
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          179..239
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          247..345
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          370..623
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ZN_FING         113..149
FT                   /note="Btk-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   REGION          157..178
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        489
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         121
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         132
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         133
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         143
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         376..384
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         398
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         206
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:12573241,
FT                   ECO:0007744|PubMed:19369195"
FT   MOD_RES         228
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         519
FT                   /note="Phosphotyrosine; by autocatalysis, LYN and JAK2"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   VARIANT         44
FT                   /note="R -> Q (in dbSNP:rs35374286)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041850"
FT   VARIANT         563
FT                   /note="R -> K (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041851"
FT   CONFLICT        514
FT                   /note="V -> F (in Ref. 1; BAA06171)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..14
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          26..41
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          45..47
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   HELIX           56..58
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          61..64
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          69..71
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          78..83
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          88..92
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   HELIX           96..110
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          118..120
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          132..134
FT                   /evidence="ECO:0007829|PDB:2LUL"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:2LUL"
SQ   SEQUENCE   631 AA;  73581 MW;  F55DECBF9916E1F9 CRC64;
     MNFNTILEEI LIKRSQQKKK TSPLNYKERL FVLTKSMLTY YEGRAEKKYR KGFIDVSKIK
     CVEIVKNDDG VIPCQNKYPF QVVHDANTLY IFAPSPQSRD LWVKKLKEEI KNNNNIMIKY
     HPKFWTDGSY QCCRQTEKLA PGCEKYNLFE SSIRKALPPA PETKKRRPPP PIPLEEEDNS
     EEIVVAMYDF QAAEGHDLRL ERGQEYLILE KNDVHWWRAR DKYGNEGYIP SNYVTGKKSN
     NLDQYEWYCR NMNRSKAEQL LRSEDKEGGF MVRDSSQPGL YTVSLYTKFG GEGSSGFRHY
     HIKETTTSPK KYYLAEKHAF GSIPEIIEYH KHNAAGLVTR LRYPVSVKGK NAPTTAGFSY
     EKWEINPSEL TFMRELGSGL FGVVRLGKWR AQYKVAIKAI REGAMCEEDF IEEAKVMMKL
     THPKLVQLYG VCTQQKPIYI VTEFMERGCL LNFLRQRQGH FSRDVLLSMC QDVCEGMEYL
     ERNSFIHRDL AARNCLVSEA GVVKVSDFGM ARYVLDDQYT SSSGAKFPVK WCPPEVFNYS
     RFSSKSDVWS FGVLMWEVFT EGRMPFEKYT NYEVVTMVTR GHRLYQPKLA SNYVYEVMLR
     CWQEKPEGRP SFEDLLRTID ELVECEETFG R
//
